Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 9, no: 2 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HZD4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 226 | 230 | PF00656 | 0.505 |
CLV_NRD_NRD_1 | 279 | 281 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.556 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.554 |
CLV_PCSK_PC7_1 | 89 | 95 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 239 | 243 | PF00082 | 0.652 |
DEG_APCC_DBOX_1 | 238 | 246 | PF00400 | 0.613 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.555 |
DOC_ANK_TNKS_1 | 224 | 231 | PF00023 | 0.492 |
DOC_CKS1_1 | 186 | 191 | PF01111 | 0.616 |
DOC_CYCLIN_yCln2_LP_2 | 292 | 298 | PF00134 | 0.616 |
DOC_MAPK_gen_1 | 212 | 221 | PF00069 | 0.522 |
DOC_MAPK_gen_1 | 285 | 294 | PF00069 | 0.605 |
DOC_PP2B_LxvP_1 | 292 | 295 | PF13499 | 0.600 |
DOC_PP4_FxxP_1 | 221 | 224 | PF00568 | 0.514 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.581 |
DOC_USP7_MATH_1 | 296 | 300 | PF00917 | 0.650 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.619 |
DOC_USP7_UBL2_3 | 63 | 67 | PF12436 | 0.514 |
DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.773 |
DOC_WW_Pin1_4 | 185 | 190 | PF00397 | 0.645 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.581 |
LIG_14-3-3_CanoR_1 | 148 | 154 | PF00244 | 0.389 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.535 |
LIG_14-3-3_CanoR_1 | 324 | 331 | PF00244 | 0.550 |
LIG_14-3-3_CanoR_1 | 89 | 93 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 94 | 102 | PF00244 | 0.502 |
LIG_Actin_WH2_2 | 52 | 69 | PF00022 | 0.505 |
LIG_BRCT_BRCA1_1 | 250 | 254 | PF00533 | 0.600 |
LIG_deltaCOP1_diTrp_1 | 267 | 277 | PF00928 | 0.425 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.460 |
LIG_FHA_1 | 311 | 317 | PF00498 | 0.530 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.653 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.626 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.604 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.683 |
LIG_FHA_2 | 332 | 338 | PF00498 | 0.637 |
LIG_LIR_Apic_2 | 183 | 189 | PF02991 | 0.552 |
LIG_LIR_Gen_1 | 251 | 262 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 267 | 276 | PF02991 | 0.477 |
LIG_LIR_Gen_1 | 37 | 48 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 160 | 166 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 251 | 257 | PF02991 | 0.556 |
LIG_LIR_Nem_3 | 26 | 31 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 37 | 43 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.321 |
LIG_MAD2 | 212 | 220 | PF02301 | 0.494 |
LIG_Rb_LxCxE_1 | 193 | 203 | PF01857 | 0.741 |
LIG_SH2_STAP1 | 149 | 153 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.632 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.505 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.678 |
LIG_SH3_3 | 263 | 269 | PF00018 | 0.544 |
LIG_SH3_CIN85_PxpxPR_1 | 220 | 225 | PF14604 | 0.385 |
LIG_TRAF2_1 | 178 | 181 | PF00917 | 0.531 |
LIG_TRAF2_2 | 48 | 53 | PF00917 | 0.508 |
MOD_CDC14_SPxK_1 | 125 | 128 | PF00782 | 0.683 |
MOD_CDK_SPxK_1 | 122 | 128 | PF00069 | 0.677 |
MOD_CDK_SPxK_1 | 185 | 191 | PF00069 | 0.599 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.744 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.643 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.577 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.685 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.627 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.630 |
MOD_GlcNHglycan | 249 | 253 | PF01048 | 0.606 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.541 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.615 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.638 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.746 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.454 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.557 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.452 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.559 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.454 |
MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.516 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.473 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.538 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.693 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.586 |
MOD_NEK2_2 | 149 | 154 | PF00069 | 0.454 |
MOD_NEK2_2 | 157 | 162 | PF00069 | 0.516 |
MOD_NEK2_2 | 84 | 89 | PF00069 | 0.449 |
MOD_PIKK_1 | 323 | 329 | PF00454 | 0.612 |
MOD_PIKK_1 | 46 | 52 | PF00454 | 0.545 |
MOD_PKA_1 | 93 | 99 | PF00069 | 0.589 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.676 |
MOD_PKA_2 | 323 | 329 | PF00069 | 0.493 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.486 |
MOD_Plk_1 | 157 | 163 | PF00069 | 0.457 |
MOD_Plk_1 | 288 | 294 | PF00069 | 0.714 |
MOD_Plk_1 | 296 | 302 | PF00069 | 0.550 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.447 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.544 |
MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.776 |
MOD_ProDKin_1 | 185 | 191 | PF00069 | 0.657 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.595 |
MOD_SUMO_for_1 | 62 | 65 | PF00179 | 0.512 |
MOD_SUMO_rev_2 | 58 | 64 | PF00179 | 0.526 |
TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.452 |
TRG_ER_diArg_1 | 210 | 213 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 277 | 280 | PF00400 | 0.483 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.546 |
TRG_Pf-PMV_PEXEL_1 | 239 | 244 | PF00026 | 0.568 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1F8 | Leptomonas seymouri | 51% | 90% |
A0A0S4IMV9 | Bodo saltans | 27% | 100% |
A0A1X0NHQ9 | Trypanosomatidae | 26% | 100% |
A0A3Q8IC12 | Leishmania donovani | 99% | 100% |
A0A3R7KKV6 | Trypanosoma rangeli | 26% | 100% |
A4HBZ4 | Leishmania braziliensis | 70% | 100% |
D0A150 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9AVC1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4QC59 | Leishmania major | 90% | 100% |
V5BHB3 | Trypanosoma cruzi | 27% | 100% |